Copyright Reports & Markets. All rights reserved.

Global Prescription Dermatological Medications Sales Market Report 2021

Request for Sample of this report
Buy now

1 Prescription Dermatological Medications Market Overview

  • 1.1 Prescription Dermatological Medications Product Scope
  • 1.2 Prescription Dermatological Medications Segment by Type
    • 1.2.1 Global Prescription Dermatological Medications Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Oral
    • 1.2.3 Topical
  • 1.3 Prescription Dermatological Medications Segment by Application
    • 1.3.1 Global Prescription Dermatological Medications Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Online Pharmacies
    • 1.3.4 Retail Pharmacies
  • 1.4 Prescription Dermatological Medications Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Prescription Dermatological Medications Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Prescription Dermatological Medications Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Prescription Dermatological Medications Price Trends (2016-2027)

2 Prescription Dermatological Medications Estimates and Forecasts by Region

  • 2.1 Global Prescription Dermatological Medications Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Prescription Dermatological Medications Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Prescription Dermatological Medications Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Prescription Dermatological Medications Revenue Market Share by Region (2016-2021)
  • 2.3 Global Prescription Dermatological Medications Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Prescription Dermatological Medications Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Prescription Dermatological Medications Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Prescription Dermatological Medications Estimates and Projections (2016-2027)
    • 2.4.2 Europe Prescription Dermatological Medications Estimates and Projections (2016-2027)
    • 2.4.3 China Prescription Dermatological Medications Estimates and Projections (2016-2027)
    • 2.4.4 Japan Prescription Dermatological Medications Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Prescription Dermatological Medications Estimates and Projections (2016-2027)
    • 2.4.6 India Prescription Dermatological Medications Estimates and Projections (2016-2027)

3 Global Prescription Dermatological Medications Competition Landscape by Players

  • 3.1 Global Top Prescription Dermatological Medications Players by Sales (2016-2021)
  • 3.2 Global Top Prescription Dermatological Medications Players by Revenue (2016-2021)
  • 3.3 Global Prescription Dermatological Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Medications as of 2020)
  • 3.4 Global Prescription Dermatological Medications Average Price by Company (2016-2021)
  • 3.5 Manufacturers Prescription Dermatological Medications Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Prescription Dermatological Medications Market Size by Type

  • 4.1 Global Prescription Dermatological Medications Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Prescription Dermatological Medications Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Prescription Dermatological Medications Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Prescription Dermatological Medications Price by Type (2016-2021)
  • 4.2 Global Prescription Dermatological Medications Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Prescription Dermatological Medications Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Prescription Dermatological Medications Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Prescription Dermatological Medications Price Forecast by Type (2022-2027)

5 Global Prescription Dermatological Medications Market Size by Application

  • 5.1 Global Prescription Dermatological Medications Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Prescription Dermatological Medications Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Prescription Dermatological Medications Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Prescription Dermatological Medications Price by Application (2016-2021)
  • 5.2 Global Prescription Dermatological Medications Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Prescription Dermatological Medications Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Prescription Dermatological Medications Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Prescription Dermatological Medications Price Forecast by Application (2022-2027)

6 North America Prescription Dermatological Medications Market Facts & Figures

  • 6.1 North America Prescription Dermatological Medications Sales by Company
    • 6.1.1 North America Prescription Dermatological Medications Sales by Company (2016-2021)
    • 6.1.2 North America Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 6.2 North America Prescription Dermatological Medications Sales Breakdown by Type
    • 6.2.1 North America Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 6.3 North America Prescription Dermatological Medications Sales Breakdown by Application
    • 6.3.1 North America Prescription Dermatological Medications Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Prescription Dermatological Medications Sales Breakdown by Application (2022-2027)

7 Europe Prescription Dermatological Medications Market Facts & Figures

  • 7.1 Europe Prescription Dermatological Medications Sales by Company
    • 7.1.1 Europe Prescription Dermatological Medications Sales by Company (2016-2021)
    • 7.1.2 Europe Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 7.2 Europe Prescription Dermatological Medications Sales Breakdown by Type
    • 7.2.1 Europe Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Prescription Dermatological Medications Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Prescription Dermatological Medications Market Facts & Figures

  • 8.1 China Prescription Dermatological Medications Sales by Company
    • 8.1.1 China Prescription Dermatological Medications Sales by Company (2016-2021)
    • 8.1.2 China Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 8.2 China Prescription Dermatological Medications Sales Breakdown by Type
    • 8.2.1 China Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 8.3 China Prescription Dermatological Medications Sales Breakdown by Application
    • 8.3.1 China 246 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Prescription Dermatological Medications Market Facts & Figures

  • 9.1 Japan Prescription Dermatological Medications Sales by Company
    • 9.1.1 Japan Prescription Dermatological Medications Sales by Company (2016-2021)
    • 9.1.2 Japan Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 9.2 Japan Prescription Dermatological Medications Sales Breakdown by Type
    • 9.2.1 Japan Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Prescription Dermatological Medications Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Prescription Dermatological Medications Market Facts & Figures

  • 10.1 Southeast Asia Prescription Dermatological Medications Sales by Company
    • 10.1.1 Southeast Asia Prescription Dermatological Medications Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Prescription Dermatological Medications Sales Breakdown by Type
    • 10.2.1 Southeast Asia Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Prescription Dermatological Medications Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Prescription Dermatological Medications Market Facts & Figures

  • 11.1 India Prescription Dermatological Medications Sales by Company
    • 11.1.1 India Prescription Dermatological Medications Sales by Company (2016-2021)
    • 11.1.2 India Prescription Dermatological Medications Revenue by Company (2016-2021)
  • 11.2 India Prescription Dermatological Medications Sales Breakdown by Type
    • 11.2.1 India Prescription Dermatological Medications Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Prescription Dermatological Medications Sales Breakdown by Type (2022-2027)
  • 11.3 India Prescription Dermatological Medications Sales Breakdown by Application
    • 11.3.1 India Prescription Dermatological Medications Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Prescription Dermatological Medications Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Prescription Dermatological Medications Business

  • 12.1 Mylan Pharmaceuticals
    • 12.1.1 Mylan Pharmaceuticals Corporation Information
    • 12.1.2 Mylan Pharmaceuticals Business Overview
    • 12.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Mylan Pharmaceuticals Prescription Dermatological Medications Products Offered
    • 12.1.5 Mylan Pharmaceuticals Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Corporation Information
    • 12.2.2 Pfizer Business Overview
    • 12.2.3 Pfizer Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Pfizer Prescription Dermatological Medications Products Offered
    • 12.2.5 Pfizer Recent Development
  • 12.3 Almirall
    • 12.3.1 Almirall Corporation Information
    • 12.3.2 Almirall Business Overview
    • 12.3.3 Almirall Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Almirall Prescription Dermatological Medications Products Offered
    • 12.3.5 Almirall Recent Development
  • 12.4 Bausch Health
    • 12.4.1 Bausch Health Corporation Information
    • 12.4.2 Bausch Health Business Overview
    • 12.4.3 Bausch Health Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bausch Health Prescription Dermatological Medications Products Offered
    • 12.4.5 Bausch Health Recent Development
  • 12.5 Barrier Therapeutics
    • 12.5.1 Barrier Therapeutics Corporation Information
    • 12.5.2 Barrier Therapeutics Business Overview
    • 12.5.3 Barrier Therapeutics Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Barrier Therapeutics Prescription Dermatological Medications Products Offered
    • 12.5.5 Barrier Therapeutics Recent Development
  • 12.6 PharmaDerm
    • 12.6.1 PharmaDerm Corporation Information
    • 12.6.2 PharmaDerm Business Overview
    • 12.6.3 PharmaDerm Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 PharmaDerm Prescription Dermatological Medications Products Offered
    • 12.6.5 PharmaDerm Recent Development
  • 12.7 Bristol-Myers Squibb
    • 12.7.1 Bristol-Myers Squibb Corporation Information
    • 12.7.2 Bristol-Myers Squibb Business Overview
    • 12.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Bristol-Myers Squibb Prescription Dermatological Medications Products Offered
    • 12.7.5 Bristol-Myers Squibb Recent Development
  • 12.8 Galderma
    • 12.8.1 Galderma Corporation Information
    • 12.8.2 Galderma Business Overview
    • 12.8.3 Galderma Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Galderma Prescription Dermatological Medications Products Offered
    • 12.8.5 Galderma Recent Development
  • 12.9 Novartis
    • 12.9.1 Novartis Corporation Information
    • 12.9.2 Novartis Business Overview
    • 12.9.3 Novartis Prescription Dermatological Medications Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Novartis Prescription Dermatological Medications Products Offered
    • 12.9.5 Novartis Recent Development

13 Prescription Dermatological Medications Manufacturing Cost Analysis

  • 13.1 Prescription Dermatological Medications Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Prescription Dermatological Medications
  • 13.4 Prescription Dermatological Medications Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Prescription Dermatological Medications Distributors List
  • 14.3 Prescription Dermatological Medications Customers

15 Market Dynamics

  • 15.1 Prescription Dermatological Medications Market Trends
  • 15.2 Prescription Dermatological Medications Drivers
  • 15.3 Prescription Dermatological Medications Market Challenges
  • 15.4 Prescription Dermatological Medications Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Prescription Dermatological Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatological Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Oral
    Topical

    Segment by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

    The Prescription Dermatological Medications market is analysed and market size information is provided by regions (countries). Segment by Application, the Prescription Dermatological Medications market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Mylan Pharmaceuticals
    Pfizer
    Almirall
    Bausch Health
    Barrier Therapeutics
    PharmaDerm
    Bristol-Myers Squibb
    Galderma
    Novartis

    Buy now